ADI
49
-2
SLB
57
4
BA
50
-2
NWS
79
-4
MTCH
40
14
SE
58
8
SJM
17
-4
BWA
48
4
SYF
95
2
NEM
38
-4
LOW
58
2
MOS
48
2
MCHP
41
-4
GOOG
75
6
GM
72
3
FDX
44
-7
WFC
82
7
MAS
60
-2
LNC
50
5
DFS
73
3
ADI
49
-2
SLB
57
4
BA
50
-2
NWS
79
-4
MTCH
40
14
SE
58
8
SJM
17
-4
BWA
48
4
SYF
95
2
NEM
38
-4
LOW
58
2
MOS
48
2
MCHP
41
-4
GOOG
75
6
GM
72
3
FDX
44
-7
WFC
82
7
MAS
60
-2
LNC
50
5
DFS
73
3
Financhill
Back

Takeda Pharmaceutical Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
25

TAK
Takeda Pharmaceutical

Last Price:
13.54
Seasonality Move:
3.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Takeda Pharmaceutical Price Quote

$13.54
-0.11 (-0.81%)
(Updated: November 12, 2024 at 5:55 PM ET)

Takeda Pharmaceutical Key Stats

Sell
25
Takeda Pharmaceutical (TAK) is a Sell
Day range:
$13.64 - $13.72
52-week range:
$12.58 - $15.08
Dividend yield:
4.48%
P/E ratio:
43.21
P/S ratio:
1.44
P/B ratio:
0.89%
Volume:
1.3M
Avg. volume:
1.5M
1-year change:
-0.29%
Market cap:
$43.3B
Revenue:
$29.5B
EPS:
$0.6

How Much Does Takeda Pharmaceutical Make?

Is Takeda Pharmaceutical Growing As A Company?

  • What Is Takeda Pharmaceutical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.1%
  • What Is Takeda Pharmaceutical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Takeda Pharmaceutical Stock Price Performance

What Is Takeda Pharmaceutical 52-Week High & Low?

Takeda Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Takeda Pharmaceutical?

Is Takeda Pharmaceutical Cash Flow Positive?

  • What Is TAK Cash Flow From Operations?
    Cash flow from operations (TTM) is $6B
  • What Is Takeda Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $306.8M
  • What Is Takeda Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.5B

Takeda Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    TAK return on invested capital is 2.37%
  • What Is Takeda Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 1.91%
  • What Is TAK Return On Equity?
    ROE is a measure of profitability and is 4.01%

Takeda Pharmaceutical Earnings Date & Stock Price

Takeda Pharmaceutical Competitors

Takeda Pharmaceutical Dividend Yield

Takeda Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 9.64% 6.41%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 16.11
Upside from Last Price: 18.05%

Major Shareholders

  • How many TAK shares are owned by institutional investors?
    196.2M TAK shares are owned by institutional investors
  • How many TAK shares are owned by insiders?
    0 TAK shares are owned by insiders